The present invention relates to novel prodrugs of gabapentin and to
pharmaceutical formulations and sustained release formulations containing
the prodrugs.
La présente invention concerne des prodrogues de roman de gabapentin et aux formulations pharmaceutiques et aux formulations soutenues de dégagement contenant les prodrogues.